Form 4 Filing for John Brendan Doyle

John Brendan Doyle, Chief Financial Officer of COGNITION THERAPEUTICS INC, reported a transaction on April 16, 2026. Doyle acquired 10,000 shares of Common Stock at a price of $1.13 per share. This transaction was made directly, and following the transaction, Doyle owns 627,509 shares of Common Stock. The filing is a Form 4, indicating a change in beneficial ownership.